Cargando…
Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been substantial progress in the pharmacologic treatment and supportive care of patients hospitalized with active COVID-19 infections. To date there have been numerous medications trialed for COVID-19 management. In t...
Autores principales: | Hall, Kimberly, Mfone, Fuhbe, Shallcross, Michael, Pathak, Vikas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Eurasian Journal of Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184028/ https://www.ncbi.nlm.nih.gov/pubmed/34177298 http://dx.doi.org/10.5152/eurasianjmed.2021.20384 |
Ejemplares similares
-
A Narrative Review of Antiviral Drugs Used for COVID-19 Pharmacotherapy
por: Kumar, Subodh, et al.
Publicado: (2021) -
Review of Pharmacotherapy for Tinnitus
por: Kim, Sang Hoon, et al.
Publicado: (2021) -
Pharmacotherapy in Coronavirus Disease 2019 and Risk of Secondary Infections: A Single-Center Case Series and Narrative Review
por: Behal, Michael, et al.
Publicado: (2021) -
Novel Pharmacotherapies in Parkinson’s Disease
por: Tizabi, Yousef, et al.
Publicado: (2021) -
Approaches to improve adherence to pharmacotherapy in patients with schizophrenia
por: Shuler, Kimberly M
Publicado: (2014)